Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 244 followers
Latest posts
Last updated about 2 hours ago
Summary of opinion: Imvanex, 19/09/2024 Positive
about 2 hours ago
Summary of opinion: Imvanex, 19/09/2024 Positive
EMA recommends extending indication of mpox vaccine to adolescents
about 2 hours ago
EMA recommends extending indication of mpox vaccine to adolescents
Human medicines European public assessment report (EPAR): Rhokiinsa, netarsudil, Date of authorisation: 19/11/2019, Revision: 4, Status: Authorised
about 3 hours ago
Human medicines European public assessment report (EPAR): Rhokiinsa, netarsudil, Date of authorisation...
Human medicines European public assessment report (EPAR): Klisyri, tirbanibulin, Date of authorisation: 16/07/2021, Revision: 3, Status: Authorised
about 3 hours ago
Human medicines European public assessment report (EPAR): Klisyri, tirbanibulin, Date of authorisation...
Opinion/decision on a Paediatric investigation plan (PIP): Viread, tenofovir disoproxil fumarate, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Infectious diseases, PIP number: P/0073/2022
about 4 hours ago
Opinion/decision on a Paediatric investigation plan (PIP): Viread, tenofovir disoproxil fumarate, decision...
Opinion/decision on a Paediatric investigation plan (PIP): Brintellix, Vortioxetine, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Psychiatry, PIP number: P/0337/2022
about 4 hours ago
Opinion/decision on a Paediatric investigation plan (PIP): Brintellix, Vortioxetine, decision type: PM...
Opinion/decision on a Paediatric investigation plan (PIP): Relvar Ellipta, vilanterol,fluticasone furoate, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Pneumology-allergology, PIP number: P/0092/2021
about 4 hours ago
Opinion/decision on a Paediatric investigation plan (PIP): Relvar Ellipta, vilanterol,fluticasone furoate, decision...
Opinion/decision on a Paediatric investigation plan (PIP): Kalydeco, ivacaftor, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Other, PIP number: P/0002/2023
about 4 hours ago
Opinion/decision on a Paediatric investigation plan (PIP): Kalydeco, ivacaftor, decision type: PM...
Opinion/decision on a Paediatric investigation plan (PIP): Zinplava, Bezlotoxumab, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Infectious diseases, PIP number: P/0135/2022
about 4 hours ago
Opinion/decision on a Paediatric investigation plan (PIP): Zinplava, Bezlotoxumab, decision type: PM...
Opinion/decision on a Paediatric investigation plan (PIP): Praluent, Alirocumab, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Endocrinology-Gynaecology-Fertility-Metabolism, PIP number: P/0550/2021
about 4 hours ago
Opinion/decision on a Paediatric investigation plan (PIP): Praluent, Alirocumab, decision type: PM...
Opinion/decision on a Paediatric investigation plan (PIP): Rozlytrek, Entrectinib, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Oncology, PIP number: P/0351/2021
about 4 hours ago
Opinion/decision on a Paediatric investigation plan (PIP): Rozlytrek, Entrectinib, decision type: PM...